(Unit: 100 Million Won)
| consolidated financial statements |
Subject
|
2021
|
2020
|
2019
|
|---|---|---|---|---|
| Sales | 3,905 | 3,348 | 4,028 | |
| Gross Profit | 43 | (322) | (213) | |
| Net income | 601 | (246) | (691) |
| separate financial statements |
Subject
|
2021
|
2020
|
2019
|
|---|---|---|---|---|
| Sales | 2,240 | 1,794 | 2,175 | |
| Gross Profit | 60 | (236) | (164) | |
| Net income | 596 | (467) | (764) |
(Unit: 100 Million Won)
| consolidated financial statements |
Subject
|
2021
|
2020
|
2019
|
|---|---|---|---|---|
| Asset | ||||
| Ⅰ. Current asset | 2,801 | 2,779 | 2,677 | |
| Ⅱ. Non-current asset | 10,292 | 9,504 | 9,058 | |
| Total Assets | 13,093 | 12,284 | 11,735 | |
| Liability | ||||
| Ⅰ. Current Liabilites | 1,713 | 5,937 | 1,701 | |
| Ⅱ. Non-Current Liabilities | 5,844 | 1,414 | 4,841 | |
| Total Liabilities | 7,557 | 7,351 | 6,542 | |
| Stockholder's Equity | ||||
| Ⅰ. Capital Stock | 3,941 | 3,940 | 3,940 | |
| Ⅱ. Other payment Capital | (256) | (255) | (255) | |
| Ⅲ. Other Capital | (493) | (493) | (479) | |
| Ⅳ. Earned surplus | 2,345 | 1,740 | 1,987 | |
| Total Stockholders Equity | 5,536 | 4,932 | 5,192 | |
| separate financial statements |
Subject
|
2021
|
2020
|
2019
|
|---|---|---|---|---|
| Asset | ||||
| Ⅰ. Current asset | 2,164 | 2,114 | 1,973 | |
| Ⅱ. Non-current asset | 10,414 | 9,670 | 9,533 | |
| Total Assets | 12,578 | 11,784 | 11,506 | |
| Liability | ||||
| Ⅰ. Current Liabilites | 1,537 | 5,762 | 1,559 | |
| Ⅱ. Non-Current Liabilities | 5,820 | 1,400 | 4,844 | |
| Total Liabilities | 7,357 | 7,162 | 6,403 | |
| Stockholder's Equity | ||||
| Ⅰ. Capital Stock | 3,941 | 3,941 | 3,941 | |
| Ⅱ. Other payment Capital | (255) | (255) | (255) | |
| Ⅲ. Other Capital | (491) | (491) | (477) | |
| Ⅳ. Earned surplus | 2,026 | 1,427 | 1,894 | |
| Total Stockholders Equity | 5,221 | 4,622 | 5,103 | |
(Unit: 100 Million Won)
| consolidated financial statements |
Subject
|
2021
|
2020
|
2019
|
|---|---|---|---|---|
| Ⅰ. Sales | 3,904 | 3,348 | 4,028 | |
| Ⅱ. Cost of sales | 2,799 | 2,508 | 2,972 | |
| Ⅲ. Gross Margin | 1,105 | 840 | 1,055 | |
| Ⅳ. Selling and Administrative Expenses | 1,062 | 1,057 | 1,176 | |
| Ⅴ. Operation Income | 43 | (322) | (213) | |
| Ⅵ. Other income | 58 | 54 | 58 | |
| Ⅶ. Other expenses | 120 | 445 | 65 | |
| Ⅷ. Finance income | 6 | 9 | 10 | |
| Ⅸ. Finance costs | 204 | 226 | 223 | |
| Ⅹ. Equity method income | 1,024 | 803 | 1 | |
| XV. Equity method Loss | - | 2 | 364 | |
| XVI. Income before income tax | 808 | (129) | (796) | |
| XVII. Income tax expenses | 207 | 117 | (104) | |
| XVIII. Continuously Operation Income | 601 | (246) | (691) | |
| XV. Discontinued Operation Income | - | - | - | |
| XVI. Net income | 601 | (246) | (691) |
| separate financial statements |
Subject
|
2021
|
2020
|
2019
|
|---|---|---|---|---|
| Ⅰ. Sales | 2,240 | 1,794 | 2,175 | |
| Ⅱ. Cost of sales | 1,344 | 1,107 | 1,361 | |
| Ⅲ. Gross Margin | 896 | 687 | 814 | |
| Ⅳ. Selling and Administrative Expenses | 836 | 923 | 978 | |
| Ⅴ. Operation Income | 60 | (236) | (164) | |
| Ⅵ. Other income | 54 | 51 | 50 | |
| Ⅶ. Other expenses | 103 | 675 | 133 | |
| Ⅷ. Finance income | 7 | 9 | 10 | |
| Ⅸ. Finance costs | 203 | 226 | 222 | |
| Ⅹ. Equity method income | 1,056 | 807 | 55 | |
| XV. Equity method Loss | 72 | 85 | 493 | |
| XVI. Income before income tax | 799 | (355) | (897) | |
| XVII. Income tax expenses | 203 | 112 | (133) | |
| XVIII. Continuously Operation Income | 596 | (467) | (764) | |
| XV. Discontinued Operation Income | - | - | - | |
| XVI. Net Income | 596 | (467) | (764) |
(Unit: 100 Million Won)
| consolidated financial statements |
Subject
|
2021
|
2020
|
2019
|
|---|---|---|---|---|
| Ⅰ. Cash Flows from Operating Activities | 244 | 293 | (224) | |
| Ⅱ. Cash Flows from Investing Activities | 114 | (56) | 186 | |
| Ⅲ. Cash Flows from Financing Activities | (550) | 148 | 69 | |
| Ⅳ. Increase or Decrease in Cash and Cash Equivalents | (192) | 384 | 31 | |
| Ⅴ. Cash and Cash Equivalent at Beginning | 705 | 321 | 289 | |
| Ⅵ. Cash and Cash Equivalent at End | 513 | 705 | 321 | |
| separate financial statements |
Subject
|
2021
|
2020
|
2019
|
|---|---|---|---|---|
| Ⅰ. Cash Flows from Operating Activities | 167 | 217 | (202) | |
| Ⅱ. Cash Flows from Investing Activities | 218 | (54) | 139 | |
| Ⅲ. Cash Flows from Financing Activities | (537) | 172 | 122 | |
| Ⅳ. Increase or Decrease in Cash and Cash Equivalents | (151) | 335 | 59 | |
| Ⅴ. Cash and Cash Equivalent at Beginning | 534 | 199 | 140 | |
| Ⅵ. Cash and Cash Equivalent at End | 383 | 534 | 199 |
